Literature DB >> 11397479

Combined histologic and molecular features reveal previously unappreciated subsets of lymphoma in AKXD recombinant inbred mice.

H C Morse1, C F Qi, S K Chattopadhyay, M Hori, L Taddesse-Heath, K Ozato, J W Hartley, B A Taylor, J M Ward, N A Jenkins, N G Copeland, T N Fredrickson.   

Abstract

Hematopoietic neoplasms developing in AKXD recombinant inbred, NFS.V(+) and ICSBP knockout mice were assessed using morphologic, cytologic and molecular criteria that relate these disorders to human lymphoma and leukemia. Lymphoma types included precursor T-cell and B-cell lymphoblastic, small lymphocytic, splenic marginal zone, follicular, and diffuse large cell (DLCL). In addition to previously defined subtypes of DLCL composed of centroblasts or immunoblasts, two additional subtypes are defined here: lymphoblastic lymphoma like (LL) and lymphoma characterized by a histiocytic reaction (HS). DLCL(HS) were distinguished from true histiocytic lymphomas by the presence of clonal Ig gene rearrangements.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11397479     DOI： 10.1016/s0145-2126(01)00022-4

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  11 in total

1.  IL-6 transgenic mouse model for extraosseous plasmacytoma.

Authors:  Alexander L Kovalchuk; Joong Su Kim; Sung Sup Park; Allen E Coleman; Jerrold M Ward; Herbert C Morse; Tadamitsu Kishimoto; Michael Potter; Siegfried Janz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

2.  The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice.

Authors:  X Hao; T N Fredrickson; S K Chattopadhyay; W Han; C-F Qi; Z Wang; J M Ward; J W Hartley; H C Morse
Journal:  Vet Pathol       Date:  2010-05       Impact factor: 2.221

Review 3.  Differentiation of rodent immune and hematopoietic system reactive lesions from neoplasias.

Authors:  Jerrold M Ward; Jerold E Rehg; Herbert C Morse
Journal:  Toxicol Pathol       Date:  2012-01-03       Impact factor: 1.902

4.  A mutant collagen XIII alters intestinal expression of immune response genes and predisposes transgenic mice to develop B-cell lymphomas.

Authors:  Anne Tuomisto; Malin Sund; Jenni Tahkola; Anne Latvanlehto; Eeva-Riitta Savolainen; Helena Autio-Harmainen; Annikki Liakka; Raija Sormunen; Jussi Vuoristo; Anne West; Riitta Lahesmaa; Herbert C Morse; Taina Pihlajaniemi
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

5.  Eef1a2 promotes cell growth, inhibits apoptosis and activates JAK/STAT and AKT signaling in mouse plasmacytomas.

Authors:  Zhaoyang Li; Chen-Feng Qi; Dong-Mi Shin; Adriana Zingone; Helen J Newbery; Alexander L Kovalchuk; Catherine M Abbott; Herbert C Morse
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

6.  Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies.

Authors:  Madhuri Warren; Yeun-Jun Chung; William J Howat; Hannah Harrison; Ralph McGinnis; Xingpei Hao; John McCafferty; Torgny N Fredrickson; Allan Bradley; Herbert C Morse
Journal:  Leuk Res       Date:  2009-08-25       Impact factor: 3.156

7.  Immunophenotype of Spontaneous Hematolymphoid Tumors Occurring in Young and Aging Female CD-1 Mice. [Corrected].

Authors:  Jerold E Rehg; Richard Rahija; Dorothy Bush; Alys Bradley; Jerrold M Ward
Journal:  Toxicol Pathol       Date:  2015-07-28       Impact factor: 1.902

8.  Retroviral insertions in the VISION database identify molecular pathways in mouse lymphoid leukemia and lymphoma.

Authors:  Keith C Weiser; Bin Liu; Gwenn M Hansen; Darlene Skapura; Kathryn E Hentges; Sujatha Yarlagadda; Herbert C Morse Iii; Monica J Justice
Journal:  Mamm Genome       Date:  2007-10-10       Impact factor: 2.957

9.  Gene expression profiling of blood to predict the onset of leukemia.

Authors:  Mario Medvedovic; Danielle Halbleib; Marian L Miller; Kathy LaDow; Maureen A Sartor; Craig R Tomlinson
Journal:  Blood Cells Mol Dis       Date:  2008-10-19       Impact factor: 3.039

10.  Stat5 synergizes with T cell receptor/antigen stimulation in the development of lymphoblastic lymphoma.

Authors:  John A Kelly; Rosanne Spolski; Panu E Kovanen; Takeshi Suzuki; Julie Bollenbacher; Cynthia A Pise-Masison; Michael F Radonovich; Stephen Lee; Nancy A Jenkins; Neal G Copeland; Herbert C Morse; Warren J Leonard
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.